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J Vet Diagn Invest 16:57–63 (2004)
Transmission of transmissible mink encephalopathy to raccoons
(Procyon lotor) by intracerebral inoculation
Amir N. Hamir,1 Janice M. Miller, Katherine I. O’Rourke, Jason C. Bartz, Mick J. Stack,
Melanie J. Chaplin
Abstract. To determine the transmissibility of transmissible mink encephalopathy (TME) agent to raccoons
and to provide information about clinical course, lesions, and suitability of currently used diagnostic procedures
for detection of transmissible spongiform encephalopathies (TSEs) in raccoons, 4 raccoon kits were inoculated
intracerebrally with a brain suspension from mink experimentally infected with TME. One uninoculated raccoon
kit served as a control. All 4 animals in the TME-inoculated group showed clinical signs of neurologic disorder
and were euthanized between 21 and 23 weeks postinoculation (PI). Necropsy examinations revealed no gross
lesions. Spongiform encephalopathy was observed by light microscopy, and the presence of protease-resistant
prion protein (PrPres) was detected by immunohistochemistry and Western blot techniques. Scrapie-associated
fibrils were observed by negative-stain electron microscopy in the brains of 3 of the 4 inoculated raccoons.
These findings confirm that TME is experimentally transmissible to raccoons and that diagnostic techniques
currently used for TSE in livestock detect prion protein in raccoon tissue. According to previously published
data, the incubation period of sheep scrapie in raccoons is 2 years, whereas chronic wasting disease (CWD)
had not shown transmission after 3 years of observation. Because incubation periods for the 3 US TSEs (scrapie,
TME, and CWD) in raccoons appear to be markedly different, it may be possible to use raccoons for differ-
entiating unknown TSE agents. Retrospective genotyping of raccoons using frozen spleens showed that the
raccoon PrP gene is identical to the mink gene at codons 179 and 224. Further studies, such as the incubation
periods of bovine spongiform encephalopathy and other isolates of scrapie, CWD, and TME in raccoons, are
needed before the model can be further characterized for differentiation of TSE agents.
Transmissible mink encephalopathy (TME) is a pro-
gressive, fatal disease of ranch mink, which has been
experimentally transmitted to cattle,23 sheep and
goats,12 monkeys,11,20 hamsters,20 mink,2 American sa-
ble (pine marten) and beech marten,17 skunks, ferrets,
and raccoons.10 Although natural cases of transmissible
spongiform encephalopathies (TSEs) have not been
documented in raccoons, the ease with which TME
can be experimentally transmitted to this species, via
both oral and parenteral routes,10 suggests that the dis-
ease may occur naturally in raccoons if TME-infected
tissues are included in the animals’ diet.5,10
Raccoons (Procyon lotor) are omnivores, and their
diet may include carrion. Therefore, they could get ex-
posed to carcasses of animals with TSEs.5,10 Although
naturally occurring TSEs have not been described in
raccoons, experimental transmissions of TME and
sheep scrapie have been documented.10,14
Primary objectives of this study were to determine
From the National Animal Disease Center, ARS, USDA, 2300
Dayton Avenue, PO Box 70, Ames, IA 50010 (Hamir, Miller), An-
imal Disease Research Unit, ARS, Pullman, WA 99164 (O’Rourke),
Department of Medical Microbiology and Immunology, Creighton
University, 2500 California Plaza, Omaha, NE 68178 (Bartz), and
Veterinary Laboratories Agency, Woodham Lane, New Haw, Wey-
bridge, Surrey KT15 3NB, UK (Stack, Chaplin). 1 Corresponding
author.
whether the TME agent could be transmitted to rac-
coon kits by intracerebral inoculation14 and to provide
information about the incubation period and clinico-
pathological findings. This information was considered
a necessary prerequisite before investigation of the
raccoon as a biological model for differentiation of
TSE agents.14
Materials and methods
Five 8-wk-old raccoon kits vaccinated against ca-
nine distemper were purchased from a breeder, as-
signed to TME-inoculated (n 5 4) and uninoculated
control (n 5 1) groups, and housed in a biosafety lev-
el-2 containment facility at the National Animal Dis-
ease Center, Ames, Iowa. The raccoons were fed dry
dog fooda twice a day, and clean water was available
ad libitum.
The inoculum was from the Stetsonville, Wisconsin
outbreak of TME in 1985, which had been biologically
cloned in mink 3 times by limiting end-point titration.3
The mink brain tissue was ground in a mechanical
grinder, and the final concentration of 10% (wt/vol)
was made with 0.9% sterile saline solution.
The experimental raccoons were inoculated intra-
cerebrally with 0.1 ml of TME brain inoculum as de-
scribed previously.14 In brief, the raccoon kits were
sedated with ketamine and xylazine mixture, a midline
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Table 1. Raccoon kits experimentally inoculated with the TME agent.*
Animal no. Sex
Intracerebral
inoculation
Clinical
signs Euthanized
Survival
time (wk)
Spongiform
encephalopathy IHC WB SAF
R1-2
R3-4
R5-6
R7-8
R9-10
F
F
F
F
F
TME
TME
TME
TME
none
1
1
1
1
2
1
1
1
1
1
22
23
21
21
28
1
1
1
1
2
1
1
1
1
2
1
1
1
1
2
NT
1
1
1
2
* IHC 5 immunohistochemistry for protease-resistant prion protein; NT 5 not tested; WB 5 Western blotc; SAF 5 scrapie-associated
fibrils; M 5 male; F 5 female; NT 5 not tested; CWD 5 chronic wasting disease; TME 5 transmissible mink encephalopathy. 1 indicates
the presence of clinical signs, lesions, or antigens. 2 indicates the absence of clinical signs, lesions, or antigens.
incision was made in the skin at the junction of the
parietal and frontal bones, and a 2-mm hole was drilled
through the calvarium. The inoculum was injected into
the midbrain using a 22-gauge, 3.5 cm long needle
while withdrawing the needle from the brain. The skin
incision was closed with a single suture. One kit (con-
trol) was not inoculated (Table 1).
Animals were euthanized with pentobarbital, and a
complete necropsy was conducted on each of the car-
casses. Brain and spinal cord together with represen-
tative samples of heart, diaphragm, tongue, masseter
muscle, lung, liver, gall bladder, kidney, pancreas, skin,
spleen, eye, mesenteric lymph node, stomach, intes-
tines, trachea, thyroids, esophagus, thoracic aorta, ad-
renal glands, salivary glands, urinary bladder, uterus,
and ovaries or prostate were immersion fixed in 10%
neutral buffered formalin. The brain (except for a
small portion of frontal cortex that was frozen) was
fixed in formalin for not less than 3 wk and was cut
into serial coronal sections of 2–4 mm width, and all
sections were processed for routine histopathology. A
small piece of proximal cervical spinal cord was fro-
zen, and the remainder of the cord was fixed in buff-
ered formalin. Four samples each of cervical, thoracic,
and lumbosacral areas of the fixed cord were selected
for histopathology. The processed tissues were embed-
ded in paraffin wax, sectioned at 5 mm, and stained
with hematoxylin and eosin (HE). Six selected tissue
sections (cerebrum, cerebellum, brain stem, and cer-
vical, thoracic, and lumbosacral spinal cord) were
stained by an immunohistochemical (IHC) method21
for detection of protease-resistant prion protein (PrPres)
with an automated processor.b A cocktail of 2 mono-
clonal primary antibodies was used. These antibodies
would recognize PrP sequences conserved in most
mammalian species in which natural TSEs have been
reported.22 For immunodetection of PrPres, a Western
blot methodc was used on frozen brain (cerebrum) as
described previously.24 Negative-stain electron micros-
copy was used to detect scrapie-associated fibrils
(SAF) in fresh brain tissue (cerebrum).25
Frozen spleens of the experimental and control rac-
coons from this study and from 4 additional raccoons
were used for characterization of the raccoon PrP gene
polymorphisms. Deoxyribonucleic acid (DNA) was
extracted from frozen spleen using a commercial kitd
following the manufacturer’s instructions. Amplifica-
tion was performed with primer pairs based on ovine,
cervid, mustelid, and canine PrP sequences. The ca-
nine primers yielded products suitable for cloning. Ge-
nomic DNA spanning codons 23–243 of the open-
reading frame was amplified using forward primer 59-
CTG CAA GAA GCG GCC GAA GCC-39 and re-
verse primer 59-CAC GGG CGG CGG GGA GAA
GAG CAT-39, using 30 cycles of denaturation, an-
nealing, and extension at 95 C (30 sec), 62 C (30 sec),
and 72 C (59 sec). Polymerase chain reaction products
were cloned into vector pCR4-TOPO using a com-
mercial kite as specified by the manufacturer. Clones
with inserts of approximately 650 bp were selected for
sequencing. Plasmid DNA was sequenced on the ABI
Prism 377 DNA Sequencer with Big Dye Terminator
chemistryf using T3 and T7 primers.
Results
Between 21 and 23 weeks after the intracerebral in-
oculations (postinoculation [PI]), all 4 inoculated ani-
mals showed clinical neurologic signs (Table 1). All
were found to be lethargic, did not respond to external
stimuli like normal raccoons, could not climb up to
their sleeping quarters, and were generally unaware of
their surroundings. Because of humane considerations,
all 4 were euthanized (2 at 21 weeks, 1 at 22 weeks,
and 1 at 23 weeks PI, Table 1). The uninoculated con-
trol raccoon was euthanized on week 28 after initiation
of the experiment.
All 4 raccoons were in good nutritional state, and
gross lesions were not present in any of the carcasses
at necropsy. Microscopic lesions of spongiform en-
cephalopathy were present in the gray matter of brain
and spinal cord sections from all clinically affected
raccoons. The severity of lesions was variable between
individual animals and within the various neuroana-
tomic sites. Spongiform change was most prominent
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in the cerebral cortex and consisted of severe extensive
vacuolation in neuropil (Fig. 1). Vacuoles were round
to oval and varied in size (up to 80 mm in diameter).
There was mild to moderate gliosis in regions affected
by spongiform change. Similar, but less severe, lesions
were present in most nuclei of the brain stem and in
gray matter of the spinal cord. Vacuolation of neuronal
perikarya, although present in isolated neurons, was
not frequently seen in the cerebral cortex but was more
common in brain stem and spinal cord sections (Fig.
2). Neuronal degeneration was not a prominent feature
in areas with spongiform change. Choroid plexus of 2
of the 4 inoculated raccoons revealed a few isolated
blood vessels with concentric areas of mineralization
(psammoma bodies). The uninoculated control raccoon
did not have spongiform lesions in central nervous
system (CNS) tissues.
Protease-resistant prion protein was detected by IHC
in the brains and spinal cords of all 4 clinical raccoons.
The anatomical distribution was widespread, appearing
throughout the brain and spinal cord (Figs. 3, 4). Most
of the reactivity was concentrated within neuronal cy-
toplasm. Staining within glial cells was uncommon,
and there was no perineuronal or perivascular staining.
Protease-resistant prion protein was not present in tis-
sue sections from the control raccoon (No. R9-10; Ta-
ble 1).
Protease-resistant prion protein was detected by
Western immunoblotting in brain material from all 4
clinical raccoons (Table 1). A clear profile of the 3
polypeptide bands (diglycosylated, monoglycosylated,
and unglycosylated) was observed in these animals
(Fig. 5).
Scrapie-associated fibrils were detected in brain tis-
sue extracts from 3 inoculated raccoons (insufficient
brain material was available from 1 inoculated rac-
coon) but not from the control animal (Table 1; Fig.
6).
The raccoon PrP gene open-reading frame between
codons 23 and 243 (GenBank AY208166) differed
from the previously reported mink PrP gene4 at 25
sites. Only 2 of these changes result in amino acid
substitutions, relatively charge-neutral substitution of
Asn for Ser at codons 46 and 107.
Discussion
Transmissible mink encephalopathy belongs to a
group of fatal neurodegenerative diseases, the TSE. It
is a rare food-borne disease of ranch mink first docu-
mented in Wisconsin in 1947.10 The origin of TME is
not known but is speculated to have originated from
sheep scrapie or from an unknown TSE in cattle.19,20
A previously reported TME transmission study in
raccoons had used adult raccoons9, and disease was
produced by means of intracerebral and oral inocula-
tions in approximately 6 and 10 months, respectively.
For the intracerebral route of inoculation, the research-
ers had used 0.3 ml of a 10% brain solution. In the
present study, similar incubation times (21–23 weeks
PI, Table 1) were achieved by inoculation of young,
recently weaned kits with 0.1 ml of 10% brain inoc-
ulum.
Microscopic spongiform lesions in the CNS tissues
were severe and diffuse in all 4 inoculated raccoons
(Table 2). These changes were most severe in the ce-
rebral cortex and were characterized by diffuse vacu-
olation of neuropil and moderate gliosis without ap-
preciable neuronal vacuolation or degeneration. These
observations are similar to those described in raccoons
experimentally infected with TME10 or sheep scrapie.14
Vacuolation of neuronal perikarya with some gliosis
was observed in the brain stem and spinal cord regions
of PrPres-positive raccoons. Neuronal degeneration,
however, was not prominent. Presence of psammoma
bodies in choroid plexus of 2 of the 4 inoculated rac-
coons was considered an incidental finding in rac-
coons.13
Brains of the inoculated raccoons were positive for
PrPres by IHC and by the Western blot techniques.
Also, SAF were observed in the brains of 3 of the 4
inoculated raccoons (Table 1). These findings confirm
that raccoons are susceptible to TME by experimental
intracerebral inoculation and will succumb to the in-
fection within 6 months PI.
The IHC localization of PrPres accumulation in
brains of TME-inoculated raccoons was most promi-
nent in the neuronal cytoplasm. A similar pattern of
PrPres distribution has previously been reported in ex-
perimental studies of scrapie transmission to raccoons
and cattle.7,8,14 It is interesting to note that the mono-
clonal antibodies used for IHC in this study detect
PrPres in raccoons with experimental TME because the
same procedure does not detect PrPres in mink with
TME (Miller, personal observation). Previously, it was
reported that several monoclonal and polyclonal anti-
bodies to PrPres failed to show immunoreactivity with
tissues from mink with TME, the only positive re-
sponse being detected with an antibody produced by
inoculation of hamsters with mouse PrP.18
It could be argued that the PrPres antigen seen in
tissue sections was residual TME material from the
inoculum. However, if this were true, then the PrPres
would most likely have been observed as locally ex-
tensive areas of PrPres in the midbrain and cerebrum
(at the site of inoculation). Instead, there was diffuse
distribution of PrPres throughout the brain and also in
the spinal cords of inoculated raccoons. In experimen-
tal studies with sheep scrapie, it has been shown that
intracerebrally inoculated material is not present in
quantity large enough to be detected by currently
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Figure 1. Brain; cerebral cortex of raccoon No. R5-6. There is severe diffuse vacuolation of the neuropil. HE. 2003.
Figure 2. Brain; medulla oblongata of raccoon No. R5-6 with moderate diffuse vacuolation of the neuropil. HE. 2003.
Figure 3. Brain; brain stem of raccoon No. R7-8. Multiple foci of PrPres staining (red) are present within neuronal perikarya. Stained
for PrPres by IHC. 3253.
Figure 4. Thoracic spinal cord of raccoon No. R5-6. The PrPres staining (red) is confined to the gray matter. Stained for PrPres by IHC. 323.
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Figure 5. Western immunoblot showing distinct profile of PrPres
(molecular weight 27–30 kD) in the 4 positive raccoons. A normal,
non–PK treated PrPc control (molecular weight 33–35 kD) is in the
first lane. Molecular weight marker positions are indicated on the
right hand side of the image. Bovine 1 and ovine 1 refer to samples
positive for bovine spongiform encephalopathy and scrapie, respec-
tively.
Figure 6. Negatively stained scrapie-associated fibrils (SAF)
observed in brain tissue extract (caudal medulla) from raccoon No.
R7-8. 78,0003.
Table 2. Severity of spongiform encephalopathy in various areas of CNS of 4 raccoons experimentally inoculated intracerebrally with
TME agent.*
Raccoon no.
Cerebral
cortex
Thalamus/
hypothalamus Hippocampus Brain stem Cerebellum
Spinal cord
Cervical Thoracic Lumbar
R1-2
R3-4
R5-6
R7-8
R9-10
11
111
111
111
2
1
111
11
11
2
1
1
11
1
2
11
11
11
11
2
2
2
2
2
2
1
1
1
1
2
1
1
1
1
2
1
1
1
11
2
* CNS 5 central nervous system; TME 5 transmissible mink encephalopathy. 2 indicates absence of lesions; 1 presence of mild lesions;
11 presence of moderate lesions; 111 presence of severe lesions.
available diagnostic methods using IHC, Western blot,
and SAF after the first few days PI.15,16
Because characterization of the raccoon PrP gene
and information concerning PrP polymorphisms were
needed before the model could be recommended for
differentiation of TSE agents, the study showed that
the raccoon PrP gene open-reading frame between co-
dons 23 and 243 differed from the previously reported
mink PrP gene at 25 sites.4 Only 2 of these changes
result in amino acid substitutions at residues 46 and
107, resulting in the relatively charge-neutral substi-
tution of Asn for Ser. Therefore, the raccoon gene is
identical to the mink gene at codons 179 and 224.
Amino acid substitutions at these sites in ferret may
influence the relatively long incubation time in that
species after experimental exposure to TME.4 How-
ever, homology at these residues is not sufficient to
result in the very short incubation times observed in
this study. The ovine and cervid PRNP genes are also
homologous to the mink and raccoon gene at residues
179 and 224 but differ at 10–15 other residues. Ad-
ditional in vitro and in vivo transmission studies using
TSE inocula from infected animals of varying PRNP
genes may provide further evidence of sites critical for
efficient interspecies transmission.
Although the intracerebral transmission route used
in the present investigation does not mimic the natural
route of infection, which in the wild would be via in-
gestion of infectious material, the study does confirm
that raccoons are susceptible to TME. In previous ex-
perimental studies conducted at the authors’ laborato-
ry,14 scrapie-inoculated raccoon kits developed TSE at
approximately 2 years PI, whereas none of several
chronic wasting disease (CWD)–inoculated kits had
developed clinical disease within 3.5 years PI. This
finding suggests that the raccoon could be used as a
laboratory model to differentiate these 3 animal TSEs
(scrapie, TME, and CWD) after an interspecies trans-
mission event. At present, the only available biological
method for TSE strain differentiation uses a mouse
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model. This method is based on the length of incu-
bation period and neuropathological lesion profile in
3–5 strains of specially bred mice.6 The mouse model
requires an average incubation of 800 days (over 2
years), and at this time can only be done at a few TSE
laboratories in Europe. In addition to these disadvan-
tages, the mouse model requires large numbers of
mice, is expensive, and also, TME cannot be trans-
mitted to mice.19,26 Therefore, a raccoon model could
prove to be a relatively inexpensive and probably a
faster method for differentiation of the 3 recognized
TSEs in the United States. This would be particularly
useful if an unknown TSE were identified, such as
occurred in 2000 in milking sheep imported from Bel-
gium to Vermont.1 Further studies are, however, nec-
essary before the raccoon can be recommended as a
biological model for TSE strain differentiation. In this
context, experimental intracerebral inoculation of bo-
vine spongiform encephalopathy (BSE) would need to
be evaluated in raccoons. Because the BSE agent ap-
pears to be more promiscuous than other TSE agents
(i.e., easily transmitted to other species such as sheep,
wild ungulates, cats, and primates), it may have a
shorter incubation period than TME in raccoons. Fur-
thermore, inoculation of other isolates of scrapie,
CWD, and TME into raccoons would indicate whether
raccoons might be a suitable model for differentiation
of agents or strains within the host species.
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